Parmax Pharma Ltd vs Source Natural Foods Herbal Supplements Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Parmax Pharma Ltd is ₹ 32 as of 05 May 15:30 . The P/E Ratio of Parmax Pharma Ltd changed from 21 on March 2021 to 0 on March 2025 . This represents a CAGR of -100.00% over 5 yearsThe P/E Ratio of Source Natural Foods & Herbal Supplements Ltd changed from 28.2 on March 2021 to 46.2 on March 2025 . This represents a CAGR of 10.38% over 5 years The Market Cap of Parmax Pharma Ltd changed from ₹ 13.28 crore on March 2021 to ₹ 15.8 crore on March 2025 . This represents a CAGR of 3.54% over 5 yearsThe Market Cap of Source Natural Foods & Herbal Supplements Ltd changed from ₹ 95.27 crore on March 2021 to ₹ 133.98 crore on March 2025 . This represents a CAGR of 7.06% over 5 years The revenue of Parmax Pharma Ltd for the Dec '25 is ₹ 4.33 crore as compare to the Sep '25 revenue of ₹ 2.54 crore. This represent the growth of 70.47% The revenue of Source Natural Foods & Herbal Supplements Ltd for the Dec '25 is ₹ 20.3 crore as compare to the Sep '25 revenue of ₹ 16.95 crore. This represent the growth of 19.76% The ebitda of Parmax Pharma Ltd for the Dec '25 is ₹ -0.19 crore as compare to the Sep '25 ebitda of ₹ -1.58 crore. This represent the decline of -87.97% The ebitda of Source Natural Foods & Herbal Supplements Ltd for the Dec '25 is ₹ 1.53 crore as compare to the Sep '25 ebitda of ₹ 1.36 crore. This represent the growth of 12.5% The net profit of Parmax Pharma Ltd changed from ₹ 0.01 crore to ₹ -0.73 crore over 7 quarters. This represents a CAGR of NaN% The net profit of Source Natural Foods & Herbal Supplements Ltd changed from ₹ 0.42 crore to ₹ 0.82 crore over 7 quarters. This represents a CAGR of 46.57% The Dividend Payout of Parmax Pharma Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Source Natural Foods & Herbal Supplements Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Parmax Pharma Ltd

Incorporated in Nov.'94, Parmax Pharma Ltd (PPL) was promoted by Jayantilal S Dhol, Purushottam J Bhalodi and Prabhudas D Hansalpara.
The Active Pharmaceutical Ingredients (API) and Contract Manufacturing Operations ( CMO) business are the key pillar of Parmax's pharmaceutical operations. The Promoters were earlier into manufacturing of bulk drugs like Ampicilin, Amoxycillin, Cephalexin, Nalidixic Acid etc.
The Company then discontinued their business activities for few years due to various reasons.
Starting from their journey as a bulk drug manufacturer and speciality chemicals in 1994; the Company had set up a plant to manufacture and market bulk drugs like amoxycillin tri-hydrate, ampicillin tri-hydrate, cephalexin mono hydrate and nalidixic acid, at Hadamtala, Gujarat, with an installed capacity of 96 TPA.

About Source Natural Foods & Herbal Supplements Ltd

Source Natural Foods &Herbal Supplements Limited was formerly incorporated as Inwinex Pharmaceuticals Limited in 1995.
The Company name was then changed from Inwinex Pharmaceuticals Limited to Source Natural Foods &Herbal Supplements Limited in 2011-12.
The Company engages in the pharmaceutical business in India.
It provides allopathic and ayurvedic formulations.
Its principal products include Organic Ashwagandha, Organic Triphala, and Organic Satavari Tablets. Company operates in the Ayurveda and herbal sphere which has been identified as one of the key sectors of growth and innovation for the Country.

FAQs for the comparison of Parmax Pharma Ltd and Source Natural Foods & Herbal Supplements Ltd

Which company has a larger market capitalization, Parmax Pharma Ltd or Source Natural Foods & Herbal Supplements Ltd?

Market cap of Parmax Pharma Ltd is 11 Cr while Market cap of Source Natural Foods & Herbal Supplements Ltd is 83 Cr

What are the key factors driving the stock performance of Parmax Pharma Ltd and Source Natural Foods & Herbal Supplements Ltd?

The stock performance of Parmax Pharma Ltd and Source Natural Foods & Herbal Supplements Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Parmax Pharma Ltd and Source Natural Foods & Herbal Supplements Ltd?

As of May 5, 2026, the Parmax Pharma Ltd stock price is INR ₹32.0. On the other hand, Source Natural Foods & Herbal Supplements Ltd stock price is INR ₹129.95.

How do dividend payouts of Parmax Pharma Ltd and Source Natural Foods & Herbal Supplements Ltd compare?

To compare the dividend payouts of Parmax Pharma Ltd and Source Natural Foods & Herbal Supplements Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.